Zepp Health Corp
NYSE:ZEPP
Intrinsic Value
Zepp Health Corp. engages in the development, manufacture, and sale of smart wearable technology devices. [ Read More ]
The intrinsic value of one ZEPP stock under the Base Case scenario is 6.5 USD. Compared to the current market price of 0.85 USD, Zepp Health Corp is Undervalued by 87%.
Valuation Backtest
Zepp Health Corp
Run backtest to discover the historical profit from buying and selling ZEPP stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Zepp Health Corp
Current Assets | 2.5B |
Cash & Short-Term Investments | 952.8m |
Receivables | 578.9m |
Other Current Assets | 972.6m |
Non-Current Assets | 2.3B |
Long-Term Investments | 1.7B |
PP&E | 111.6m |
Intangibles | 174.8m |
Other Non-Current Assets | 346m |
Current Liabilities | 1.2B |
Accounts Payable | 479.8m |
Accrued Liabilities | 152.6m |
Short-Term Debt | 566.4m |
Other Current Liabilities | 23.8m |
Non-Current Liabilities | 1.1B |
Long-Term Debt | 861.4m |
Other Non-Current Liabilities | 225m |
Earnings Waterfall
Zepp Health Corp
Revenue
|
3B
CNY
|
Cost of Revenue
|
-2.3B
CNY
|
Gross Profit
|
671.2m
CNY
|
Operating Expenses
|
-968.5m
CNY
|
Operating Income
|
-297.3m
CNY
|
Other Expenses
|
18.2m
CNY
|
Net Income
|
-279.1m
CNY
|
Free Cash Flow Analysis
Zepp Health Corp
What is Free Cash Flow?
ZEPP Profitability Score
Profitability Due Diligence
Zepp Health Corp's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Score
Zepp Health Corp's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
ZEPP Solvency Score
Solvency Due Diligence
Zepp Health Corp's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Score
Zepp Health Corp's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ZEPP Price Targets Summary
Zepp Health Corp
According to Wall Street analysts, the average 1-year price target for ZEPP is 4.01 USD with a low forecast of 2.93 USD and a high forecast of 5.21 USD.
Shareholder Return
ZEPP Price
Zepp Health Corp
Average Annual Return | -28.32% |
Standard Deviation of Annual Returns | 41.45% |
Max Drawdown | -96% |
Market Capitalization | 51.9m USD |
Shares Outstanding | 61 038 100 |
Percentage of Shares Shorted | 0.01% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Zepp Health Corp. engages in the development, manufacture, and sale of smart wearable technology devices. The company is headquartered in Hefei, Anhui. The company went IPO on 2018-02-08. The company has developed a platform of proprietary technology including artificial intelligence (AI) chips, biometric sensors, and health data algorithms. The company is engaged in developing smart wearable technology. The company designs and develops biometric and activity data-driven fitness and smart watches. The company markets its products under the brand name, Amazfit and is the sole partner for Xiaomi wearable products. The products includes Amazfit BIP, Amazfit pace, Amazfit equator, Amazfit ARC, and accessories, such as sports bands, watch straps, ear buds, charging units, and core trackers. The smart watches provides activity tracking, sleep tracking, smart notifications from mobile devices, GPS, heart rate sensing, water resistance, wireless syncing with mobile phones. The company also provides a mobile application to keep track of the fitness information, set alarms and receive call notifications on the smart watch.
Contact
IPO
Employees
Officers
The intrinsic value of one ZEPP stock under the Base Case scenario is 6.5 USD.
Compared to the current market price of 0.85 USD, Zepp Health Corp is Undervalued by 87%.